Inventor · disambiguated record
William D. Kerns
Also filed as: KERNS DVM MS DACVP WILLIAM D · KERNS WILLIAM · KERNS WILLIAM D
6 granted patents·10 pending applications·27 citations·filing 1992–2022
80Inventor score
Files withSYNCHRONEURON INC10CAN FITE BIOPHARMA LTD1ROSSIGNOL DANIEL P1SMITHKLINE BEECHAM CORP1SYCHRONEURON INC1
Top patents by PatentIndex Score
16 records- 0193US9427420B2Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2014·Granted Aug 30, 2016·11 cites·4 claims
- 0292US9421178B2Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2013·Granted Aug 23, 2016·10 cites·9 claims
- 0388US9421179B2Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2013·Granted Aug 23, 2016·5 cites·15 claims
- 0471US10166207B2Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2014·Granted Jan 1, 2019·1 cites·9 claims
- 0565US10512621B2Methods of treating posttraumatic stress disorder with acamprosate saltsSYNCHRONEURON INC·Filed 2016·Granted Dec 24, 2019·0 cites·9 claims
- 0665US2013224292A1Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2013·Application pending·0 cites
- 0764US2013143867A1Acamprosate formulations, methods of using the same, and combinations comprising the sameSYCHRONEURON INC·Filed 2013·Application pending·0 cites
- 0860US2020061003A1Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2019·Application pending·0 cites
- 0956US2024293405A1(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl-acrylamide inhibitors of egfr for use in the treatment of brain tumorsZHAO JEAN·Filed 2022·Application pending·0 cites
- 1051US2016081938A1Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2015·Application pending·0 cites
- 1151US2005215517A1Use of an anti-endotoxin drug in the prevention and treatment of diseaseROSSIGNOL DANIEL P·Filed 2004·Application pending·0 cites
- 1251US2005101560A1Method of treating an individual with methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl] beta-D-ibofuronamideCAN FITE BIOPHARMA LTD·Filed 2003·Application pending·0 cites
- 1349US2015250746A1Acamprosate formulations, methods of using the same, and combinations comprising the sameSYNCHRONEURON INC·Filed 2015·Application pending·0 cites
- 1449US2022184007A1FormulationsSYNCHRONEURON INC·Filed 2020·Application pending·0 cites
- 1548US2003130212A1Administration of an anti-endotoxin drug by intravenous infusionFiled 2002·Application pending·0 cites
- 1625US5455247AMethods for the treatment of hyperlipidemia using azaspiranesSMITHKLINE BEECHAM CORP·Filed 1992·Granted Oct 3, 1995·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when William D. Kerns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →